Breast cancer survivors may have increased risk of thyroid cancer
the ONA take:
According to preliminary findings presented at the annual meeting of the Endocrine Society in San Diego, California, researchers at Columbia University Medical Center in New York City have found that female breast cancer survivors may be at an increased risk for developing thyroid cancer.
For the study, researchers analyzed government data from over 700,000 American women treated for breast cancer.
They found that women had a higher-than-average risk for developing thyroid cancer, mostly within 5 years of the breast cancer diagnosis.
The researchers estimated that a 40-year-old female breast cancer survivor's risk of developing thyroid cancer in the next 10 years was 16% and 12% for a 50-year-old woman, compared with 0.3% for the average U.S. woman.
The findings do not make it clear what causes the association, but it may be related to the thyroid gland being exposed to radiation treatment for breast cancer. In general, the incidence of thyroid cancer is increasing in the United States, possibly due to better detection with the increasing use of thyroid ultrasound.
Female breast cancer survivors may be at an increased risk for developing thyroid cancer.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|